Blackford provides infrastructure and access to a clinical application ecosystem focused on imaging and analytics. Under the agreement, Blackford will continue to operate as a standalone company.
The details of the acquisition were not disclosed; however, Bayer said it plans to close the deal later this year pending the satisfaction of customary closing conditions, according to a Jan. 18 release from Bayer.
The aim of the acquisition is to drive innovation in radiology, including the development and adoption of AI within the clinical workflow, as well as advance Bayer’s position in digital medical imaging.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
